SCHEMBL25166343

SCHEMBL25166343

CC(C)(C)OC(=O)Nc1cc2c(c(OC(=O)OC(C)(C)C)c1)OCCO2

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPSR1 Q6W5P4 2/20 0.47
MEN1 O00255 2/20 0.47
KMT2A Q03164 2/20 0.47
HPGD P15428 1/20 0.47
PLK1 P53350 1/20 0.40
CYP1A2 P05177 1/20 0.39
CYP2C19 P33261 1/20 0.39
MAPT P10636 2/20 0.36
CA12 O43570 1/20 0.36
CA1 P00915 1/20 0.36
CA9 Q16790 1/20 0.36
ALDH1A1 P00352 2/20 0.36
POLB P06746 2/20 0.36
KDM4E B2RXH2 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
PRKDC P78527 1/20 0.35
NPC1 O15118 3/20 0.34
RAB9A P51151 3/20 0.34
GAA P10253 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31107875 0.83 HPGD (0.50) NPSR1MEN1KMT2AHPGDPLK1
SCHEMBL25166337 0.83 HPGD (0.50) NPSR1MEN1KMT2AHPGDPLK1
SCHEMBL31108023 0.82 MEN1 (0.46) NPSR1MEN1KMT2AHPGDPLK1
SCHEMBL25166306 0.82 MEN1 (0.46) NPSR1MEN1KMT2AHPGDPLK1
SCHEMBL31108052 0.78 ACHE (0.46) NPSR1MEN1KMT2AHPGDALDH1A1
SCHEMBL30330061 0.78 ACHE (0.46) NPSR1MEN1KMT2AHPGDALDH1A1
SCHEMBL8342099 0.76 CYP1A2 (0.63) NPSR1MEN1KMT2AHPGDCYP1A2
SCHEMBL31187750 0.75 HPGD (0.46) NPSR1MEN1KMT2AHPGDCYP1A2
SCHEMBL30330289 0.73 NPC1 (0.39) NPSR1MEN1KMT2AHPGDCYP1A2
SCHEMBL25166367 0.73 NPC1 (0.42) NPSR1MEN1KMT2AHPGDCYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118647610-A Novel modulators of EHMT1 and EHMT2 and therapeutic uses thereof 探戈医药股份有限公司 2024-09-13 CN disclosed
EP-4416143-A1 NOVEL MODULATORS OF EHMT1 AND EHMT2 AND THERAPEUTIC USE THEREOF Tango Therapeutics, Inc. (US) 2024-08-21 EP disclosed
WO-2023064586-A1 NOVEL MODULATORS OF EHMT1 AND EHMT2 AND THERAPEUTIC USE THEREOF TANGO THERAPEUTICS, INC. (US) 2023-04-20 WO disclosed
WO-2023064586-A1 NOVEL MODULATORS OF EHMT1 AND EHMT2 AND THERAPEUTIC USE THEREOF TANGO THERAPEUTICS, INC. (US) 2023-04-20 WO disclosed